Innovative method using circulating tumor cells for prediction of the effects of induction therapy on locally advanced non-small cell lung cancer

[1] Jemal A(2011)Global cancer statistics CA Cancer J Clin 61 69-90

[2] Bray F(2007)Survival after recurrent nonsmall-cell lung cancer after complete pulmonary resection Ann Thorac Surg 83 409-417

[3] Center MM(2007)The present status of postoperative adjuvant chemotherapy for completely resected non-small cell lung cancer Annals of thoracic and cardiovascular surgery : official journal of the Association of Thoracic and Cardiovascular Surgeons of Asia 13 73-77

[4] Ferlay J(2011)Japanese lung cancer registry study of 11,663 surgical cases in 2004: demographic and prognosis changes over decade Journal of thoracic oncology: official publication of the International Association for the Study of Lung Cancer 6 1229-1235

[5] Ward E(2007)Induction chemoradiotherapy (carboplatin-taxane and concurrent 50-Gy radiation) for bulky cN2, N3 non-small cell lung cancer J Thorac Cardiovasc Surg 133 1179-1185

[6] Forman D(2006)Correlation of FDG-PET findings with histopathology in the assessment of response to induction chemoradiotherapy in non-small cell lung cancer Eur J Nucl Med Mol Imaging 33 140-147

[7] Sugimura H(1889)The distribution of secondary growths in cancer of the breast Lancet 133 571-573

[8] Nichols FC(2011)Preoperative circulating tumor cell detection using the isolation by size of epithelial tumor cell method for patients with lung cancer is a new prognostic biomarker Clinical cancer research: an official journal of the American Association for Cancer Research 17 827-835

[9] Yang P(2009)Circulating tumor cell as a diagnostic marker in primary lung cancer Clinical cancer research: an official journal of the American Association for Cancer Research 15 6980-6986

[10] Allen MS(2012)Circulating tumour cells, their role in metastasis and their clinical utility in lung cancer Lung cancer (Amsterdam, Netherlands) 76 19-25

[1] Jemal A(2011)Global cancer statistics CA Cancer J Clin 61 69-90

[2] Bray F(2007)Survival after recurrent nonsmall-cell lung cancer after complete pulmonary resection Ann Thorac Surg 83 409-417

[3] Center MM(2007)The present status of postoperative adjuvant chemotherapy for completely resected non-small cell lung cancer Annals of thoracic and cardiovascular surgery : official journal of the Association of Thoracic and Cardiovascular Surgeons of Asia 13 73-77

[4] Ferlay J(2011)Japanese lung cancer registry study of 11,663 surgical cases in 2004: demographic and prognosis changes over decade Journal of thoracic oncology: official publication of the International Association for the Study of Lung Cancer 6 1229-1235

[5] Ward E(2007)Induction chemoradiotherapy (carboplatin-taxane and concurrent 50-Gy radiation) for bulky cN2, N3 non-small cell lung cancer J Thorac Cardiovasc Surg 133 1179-1185

[6] Forman D(2006)Correlation of FDG-PET findings with histopathology in the assessment of response to induction chemoradiotherapy in non-small cell lung cancer Eur J Nucl Med Mol Imaging 33 140-147

[7] Sugimura H(1889)The distribution of secondary growths in cancer of the breast Lancet 133 571-573

[8] Nichols FC(2011)Preoperative circulating tumor cell detection using the isolation by size of epithelial tumor cell method for patients with lung cancer is a new prognostic biomarker Clinical cancer research: an official journal of the American Association for Cancer Research 17 827-835

[9] Yang P(2009)Circulating tumor cell as a diagnostic marker in primary lung cancer Clinical cancer research: an official journal of the American Association for Cancer Research 15 6980-6986

[10] Allen MS(2012)Circulating tumour cells, their role in metastasis and their clinical utility in lung cancer Lung cancer (Amsterdam, Netherlands) 76 19-25